MARCIA BERNARD: Open Payments
NPI 1346421328 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 19 payments from 9 companies in 2025. Trend: 2023 $394 · 2024 $434 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $176 |
| Braeburn Inc. | 1 | $119 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
| Lundbeck LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, BRIXADI, INGREZZA, REXULTI, ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR, COBENFY.
Industry payments across CA — which companies pay providers there.
